MCID: CNN002
MIFTS: 42

Cannabis Abuse

Categories: Mental diseases

Aliases & Classifications for Cannabis Abuse

Summaries for Cannabis Abuse

Disease Ontology : 12 A substance abuse that involves the recurring use of cannabis despite negative consequences.

MalaCards based summary : Cannabis Abuse, also known as marijuana abuse, is related to cannabis dependence and substance abuse. An important gene associated with Cannabis Abuse is CNR2 (Cannabinoid Receptor 2), and among its related pathways/superpathways are Ras signaling pathway and Neuroscience. The drugs Dronabinol and Dopamine have been mentioned in the context of this disorder. Affiliated tissues include testes, brain and lung.

Related Diseases for Cannabis Abuse

Diseases related to Cannabis Abuse via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 57)
# Related Disease Score Top Affiliating Genes
1 cannabis dependence 32.7 CNR1 COMT
2 substance abuse 29.8 BDNF COMT
3 disease of mental health 29.3 BDNF CNR1 COMT
4 anxiety 29.3 BDNF CNR1 COMT
5 schizophrenia 10.5
6 neuropathy, hereditary sensory and autonomic, type v 10.2 BDNF NGF
7 adult astrocytic tumour 10.2 BDNF NGF
8 paine syndrome 10.2 BDNF NGF
9 ocular dominance 10.2 BDNF NGF
10 interstitial cystitis 10.1 BDNF NGF
11 tendinosis 10.1 BDNF CNR1
12 amnestic disorder 10.1 BDNF CNR1
13 autonomic nervous system neoplasm 10.1 BDNF NGF
14 peripheral nervous system neoplasm 10.1 BDNF NGF
15 toxic encephalopathy 10.1 BDNF NGF
16 diabetic neuropathy 10.0 CNR1 NGF
17 alcohol abuse 10.0 BDNF CNR1
18 traumatic brain injury 10.0 BDNF COMT
19 brain injury 9.9 BDNF COMT
20 paranoid schizophrenia 9.9 BDNF COMT
21 postpartum depression 9.9 BDNF COMT
22 borderline personality disorder 9.9 BDNF COMT
23 personality disorder 9.9 BDNF COMT
24 substance dependence 9.9 BDNF CNR1
25 polysubstance abuse 9.9 CNR1 COMT
26 bipolar i disorder 9.9 BDNF COMT
27 mental depression 9.9 BDNF COMT
28 myocardial infarction 9.9
29 membranous nephropathy 9.9
30 acute myocardial infarction 9.9
31 glomerulonephritis 9.9
32 atrial fibrillation 9.9
33 epilepsy 9.9
34 human immunodeficiency virus infectious disease 9.9
35 cerebrovascular disease 9.9
36 depression 9.9
37 somatoform disorder 9.9 COMT NGF
38 generalized anxiety disorder 9.9 BDNF COMT
39 central nervous system disease 9.9 BDNF CNR1 NGF
40 chiari malformation type i 9.9
41 chiari malformation type ii 9.9
42 alexithymia 9.9
43 depersonalization disorder 9.9
44 myelitis 9.9
45 cocaine dependence 9.9
46 chiari malformation 9.9
47 transverse myelitis 9.9
48 drug dependence 9.9 BDNF CHRNB3 CNR1
49 bulimia nervosa 9.8 BDNF COMT
50 schizoaffective disorder 9.8 BDNF COMT

Graphical network of the top 20 diseases related to Cannabis Abuse:



Diseases related to Cannabis Abuse

Symptoms & Phenotypes for Cannabis Abuse

Drugs & Therapeutics for Cannabis Abuse

Drugs for Cannabis Abuse (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 464)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dronabinol Approved, Illicit Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 1972-08-3 16078
2
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 62-31-7, 51-61-6 681
3
Risperidone Approved, Investigational Phase 4,Phase 2,Phase 1,Not Applicable 106266-06-2 5073
4
Ethanol Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 64-17-5 702
5
Buprenorphine Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 2,Phase 1,Not Applicable 52485-79-7 644073 40400
6
Acetylcysteine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 616-91-1 12035
7
Cocaine Approved, Illicit Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 50-36-2 446220 5760
8
leucovorin Approved Phase 4,Phase 2 58-05-9 143 6006
9
Naltrexone Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 16590-41-3 5360515
10
Clozapine Approved Phase 4,Not Applicable 5786-21-0 2818
11
Buspirone Approved, Investigational Phase 4,Phase 2 36505-84-7 2477
12
Nicotine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 54-11-5 89594 942
13
Topiramate Approved Phase 4,Phase 2 97240-79-4 5284627
14
Bupropion Approved Phase 4,Phase 2,Not Applicable 34841-39-9, 34911-55-2 444
15
Fluoxetine Approved, Vet_approved Phase 4,Phase 2 54910-89-3 3386
16
Tranexamic Acid Approved Phase 4 1197-18-8 5526
17
Budesonide Approved Phase 4 51333-22-3 5281004 63006
18
Sofosbuvir Approved Phase 4 1190307-88-0 45375808
19
Ledipasvir Approved Phase 4 1256388-51-8 67505836
20
Lixisenatide Approved Phase 4 320367-13-3
21
Metformin Approved Phase 4,Phase 2 657-24-9 14219 4091
22
Naloxone Approved, Vet_approved Phase 4,Phase 2,Phase 1,Not Applicable 465-65-6 5284596
23
Lorazepam Approved Phase 4,Phase 1 846-49-1 3958
24
Progesterone Approved, Vet_approved Phase 4,Phase 2,Not Applicable,Early Phase 1 57-83-0 5994
25
Methylphenidate Approved, Investigational Phase 4,Phase 3,Phase 1 113-45-1 4158
26
Morphine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 57-27-2 5288826
27
Ondansetron Approved Phase 4 99614-02-5 4595
28
Haloperidol Approved Phase 4 52-86-8 3559
29
Brexpiprazole Approved, Investigational Phase 4 913611-97-9 11978813
30
Physostigmine Approved, Investigational Phase 4 57-47-6 5983
31
Cefazolin Approved Phase 4 25953-19-9 33255 656510
32
Cefdinir Approved Phase 4 91832-40-5 6915944
33
Cefuroxime Approved Phase 4 55268-75-2 5479529 5361202
34
Sulfamethoxazole Approved Phase 4 723-46-6 5329
35
Trimethoprim Approved, Vet_approved Phase 4 738-70-5 5578
36
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
37
Aripiprazole Approved, Investigational Phase 4,Phase 2 129722-12-9 60795
38
Ibuprofen Approved Phase 4,Not Applicable 15687-27-1 3672
39
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 2 59-30-3 6037
40 Analgesics, Non-Narcotic Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1,Not Applicable
41 Hormone Antagonists Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1,Not Applicable
42 Neurotransmitter Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
43 Psychotropic Drugs Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
44 Analgesics Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
45 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1,Not Applicable
46 Olive Phase 4,Phase 1,Phase 2
47 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
48 Cannabinoid Receptor Agonists Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1,Not Applicable
49 Hallucinogens Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1,Not Applicable
50 Hormones Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1,Not Applicable

Interventional clinical trials:

(show top 50) (show all 780)
# Name Status NCT ID Phase Drugs
1 Add on Study on Δ9-THC Treatment for Posttraumatic Stress Disorders (PTSD) Unknown status NCT00965809 Phase 4 Tetrahydrocannabinol
2 Impact of Insecticide Resistance on Vector Control Unknown status NCT01713517 Phase 4
3 Clozapine for Cannabis Use in Schizophrenia Completed NCT01639872 Phase 4 Clozapine;Risperidone
4 Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual Completed NCT00498550 Phase 4 Clozapine;Treatment as usual
5 Buspirone Treatment for Marijuana Dependence Completed NCT00875836 Phase 4 Buspirone;Placebo
6 Nicotine Patch for Marijuana Withdrawal Completed NCT01400243 Phase 4 Nicotine;Placebo Patch
7 Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption and Bipolar Mania Completed NCT00393978 Phase 4 Quetiapine and placebo;Quetiapine and Topiramate
8 Improving Substance Use and Clinical Outcomes in Heavy Cannabis Users With Quetiapine Completed NCT01153490 Phase 4
9 Bupropion for ADHD in Adolescents With Substance Use Disorder Completed NCT00936299 Phase 4 Bupropion
10 Substance Dependent Teens - Impact of Treating Depression Study 1 - 1 Completed NCT00061113 Phase 4 Fluoxetine + outpatient cognitive behavioral therapy;fluoxetine;placebo + CBT
11 Role of Tranexamic Acid Versus Uterine Cooling at Caesarean Section Completed NCT02780245 Phase 4 Tranexamic Acid
12 The Impact Of The Addition Of Budesonide To Low-Pressure, High-Volume Saline Sinus Irrigation For Chronic Rhinosinusitis Completed NCT02696850 Phase 4 Budesonide;Saline alone
13 The Effects of Cannabinoid on Patients With Non-GERD Related Non Cardiac Chest Pain Completed NCT01598207 Phase 4 Marinol;Placebo
14 Immunologic Effects of HCV Therapy With HARVONI in HCV Genotype 1 Chronically Mono-infected Active and Former IDUs Completed NCT02347345 Phase 4 Harvoni (Fixed dose combination ledipasvir/sofosbuvir)
15 Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine in Young Adults and Its Effects on Functional Outcomes Completed NCT00510276 Phase 4 Atomoxetine hydrochloride;Placebo
16 Lixisenatide-The Effects on Glucose and Lipid Metabolism in Type 2 Diabetes Completed NCT02049034 Phase 4
17 A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users (P05042)(COMPLETED) Completed NCT00604188 Phase 4 Suboxone (SCH 000484);Subutex (SCH 028444)
18 Safety and Efficacy of Medical Cannabis Oil in the Treatment of Patients With Chronic Pain Recruiting NCT03337503 Phase 4 THC and CDB in a 1 to 1 ratio;Experimental: THC and CBD in a 1 to 2 ratio;High CBD with trace THC oil
19 Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC) Recruiting NCT03056482 Phase 4 Ondansetron 8mg;Haloperidol 0.05mg/kg;Haloperidol 0.1mg/kg
20 N-acetylcysteine for the Treatment of Cannabis Dependence: Working Mechanisms Recruiting NCT03221231 Phase 4 N-acetylcysteine;Placebo Oral Tablet
21 Brexpiprazole Study Recruiting NCT03526354 Phase 4 Brexpiprazole
22 Treatment of Adolescent Antimuscarinic (Anticholinergic) Toxidrome Recruiting NCT03090620 Phase 4 Physostigmine;Lorazepam
23 Progesterone and Brain Imaging Study Recruiting NCT01954966 Phase 4 Progesterone;Placebo
24 Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions Recruiting NCT03014687 Phase 4 Placebo;Oral Antibiotics cefdinir or trimethoprim/sulfamethoxazole
25 Cannabinoids for Pain Control During Medical Abortion Active, not recruiting NCT03604341 Phase 4 Dronabinol 5mg Cap
26 Strong African American Families STEPS Project Active, not recruiting NCT03590132 Phase 4
27 Biomarkers of Injectable Extended Release Naltrexone Treatment Active, not recruiting NCT02324725 Phase 4 Naltrexone
28 Effects of THC and Alcohol on Driving Performance Not yet recruiting NCT03555968 Phase 4 THC 0;THC 125;THC 250
29 A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity Not yet recruiting NCT03785223 Phase 4 Methylphenidate Hydrochloride Controlled-Release Capsules;Placebo Capsule
30 Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusE Terminated NCT00687609 Phase 4 Atomoxetine
31 Conversion to Embeda With Rescue Trial Terminated NCT01179191 Phase 4 morphine sulfate and naltrexone hydrochloride (EMBEDA)
32 Improving Outcomes in Psychosis Associated With Substance Use Using Aripiprazole Withdrawn NCT01155544 Phase 4
33 A Comparison of Adolescent Group Therapy and Transitional Family Therapy for Adolescent Alcohol and Drug Abusers Unknown status NCT00484367 Phase 2, Phase 3
34 Brief Counseling to Reduce Injuries Among Emergency Department Patients Who Report Alcohol and Substance Use Unknown status NCT00547963 Phase 2, Phase 3
35 CANDIS-II: Evaluation of the Cognitive-behavioral Treatment Programme CANDIS Unknown status NCT00673647 Phase 3
36 Anesthetic Premedication With a Cannabis Extract (Cannapremed) Unknown status NCT02283281 Phase 2, Phase 3 Tetrahydrocannabinol;Acetaminophen;Midazolam;Dummy oromucosal spray
37 Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients Unknown status NCT02802540 Phase 2, Phase 3 Nabilone;Placebo
38 Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Disorder and Substance Abuse Disorder Completed NCT00194129 Phase 3 Lithium;Divalproex;Placebo
39 Teen Marijuana Check-Up Completed NCT01109563 Phase 3
40 Vaporized Cannabis and Spinal Cord Injury Pain Completed NCT01555983 Phase 2, Phase 3 Vaporization of Cannabis
41 Nabilone for Cannabis Dependence: A Pilot Study Completed NCT01347762 Phase 2, Phase 3 Nabilone;Placebo
42 Facilitating the Behavioral Treatment of Cannabis Use Disorder Completed NCT02946489 Phase 2, Phase 3 CI-581a
43 The Role of Sleep in the Treatment of Cannabis Use Disorders Completed NCT01685073 Phase 2, Phase 3 Zolpidem extended-release
44 Nabilone & Marijuana Addiction Completed NCT01025700 Phase 2, Phase 3 Cesemat
45 A Brief Marijuana Intervention for Adolescent Women - 1 Completed NCT00227864 Phase 3
46 Combined Pharmacotherapy for Cannabis Dependency Completed NCT01020019 Phase 2, Phase 3 Dronabinol;Placebo;Lofexidine
47 Safety and Efficacy on Spasticity Symptoms of a Cannabis Sativa Extract in Motor Neuron Disease Completed NCT01776970 Phase 2, Phase 3 Cannabis Sativa extract Oromucosal spray
48 Emerging Adults Who Use Alcohol and Marijuana Completed NCT01473719 Phase 3
49 Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment Completed NCT01675661 Phase 3 N-Acetylcysteine;Placebo
50 A Study of Cannabis Based Medicine Extracts and Placebo in Patients With Pain Due to Spinal Cord Injury Completed NCT01606202 Phase 3 GW-1000-02;Placebo

Search NIH Clinical Center for Cannabis Abuse

Genetic Tests for Cannabis Abuse

Anatomical Context for Cannabis Abuse

MalaCards organs/tissues related to Cannabis Abuse:

42
Testes, Brain, Lung, Liver, Colon, Breast, Spinal Cord

Publications for Cannabis Abuse

Articles related to Cannabis Abuse:

(show top 50) (show all 145)
# Title Authors Year
1
Cannabis Abuse or Dependence During Pregnancy: A Population-Based Cohort Study on 12 Million Births. ( 30448107 )
2019
2
Neuregulin-1 is increased in schizophrenia patients with chronic cannabis abuse: Preliminary results. ( 30799217 )
2019
3
Cannabis abuse and dependence in kidney transplant candidates. ( 31003856 )
2019
4
The Cannabis Abuse Screening Test and the DSM-5 in the general population: Optimal thresholds and underlying common structure using multiple factor analysis. ( 29124816 )
2018
5
Age Invariance of the Cannabis Abuse Screening Test in a Probabilistic Sample of Cannabis Users. ( 29495016 )
2018
6
Cannabinoids for the treatment of cannabis abuse disorder. ( 30339139 )
2018
7
Influence of the type of childhood violence on cannabis abuse and dependence among adolescents: a systematic review and meta-analysis. ( 30627731 )
2018
8
Synergistic effects of marijuana abuse and HIV infection on neural activation during a cognitive interference task. ( 30239074 )
2018
9
The Cannabis Abuse Screening Test (CAST) revisited: examining measurement invariance by age. ( 27723274 )
2017
10
Assessing the structure of the CAST (Cannabis Abuse Screening Test) in 13 European countries using multigroup analyses. ( 27981662 )
2017
11
Long lasting effects of chronic heavy cannabis abuse. ( 28314070 )
2017
12
Acute myocardial infarction and ischemic stroke coexistence due to marijuana abuse in an adolescent. ( 27389155 )
2016
13
Shifting the Paradigm: Adolescent Cannabis Abuse and the Need for Early Intervention. ( 26800275 )
2016
14
Cannabis Abuse Is Increasing and Associated with Increased Emergency Department Utilization in Gastroenterology Patients. ( 26935430 )
2016
15
Transverse myelitis associated with heroin and cannabis abuse: a new issue from the past. ( 27003705 )
2016
16
Small Molecule Detection in Saliva Facilitates Portable Tests of Marijuana Abuse. ( 27434697 )
2016
17
Marijuana Abuse in Singapore. ( 27922141 )
2016
18
The influence of age and gender on the likelihood of endorsing cannabis abuse/dependence criteria. ( 25481449 )
2015
19
Methamphetamine and cannabis abuse in adolescence: a quasi-experimental study on specific and long-term neurocognitive effects. ( 25636791 )
2015
20
Cannabis abuse effects on prepulse inhibition in patients with first episode psychosis in schizophrenia. ( 25716487 )
2015
21
Sex-dependent vulnerability to cannabis abuse in adolescence. ( 25941498 )
2015
22
Properties of the Cannabis Abuse Screening Test (CAST) in the general population. ( 26077195 )
2015
23
Commentary on Kosty et al. (2015): Cannabis abuse from one generation to the next-a heightened vulnerability in women? ( 26094497 )
2015
24
Concomitant cannabis abuse/dependence in patients treated with opioids for non-cancer pain. ( 26246069 )
2015
25
Authors' Response to "Parental Cannabis Abuse and Accidental Intoxication in Children: Prevention by Detecting Neglectful Situations and At-Risk Families". ( 26427950 )
2015
26
Pathways to psychosis in cannabis abuse. ( 23491968 )
2015
27
The association between cannabis abuse and subsequent schizophrenia: a Swedish national co-relative control study. ( 24990397 )
2015
28
Functioning of cannabis abuse and dependence criteria across two different countries: the United States and The Netherlands. ( 25363693 )
2015
29
The impacts of marijuana dispensary density and neighborhood ecology on marijuana abuse and dependence. ( 26154479 )
2015
30
Cortical thinness and volume differences associated with marijuana abuse in emerging adults. ( 26249265 )
2015
31
Parental cannabis abuse and accidental intoxications in children: prevention by detecting neglectful situations and at-risk families. ( 25407034 )
2014
32
Cannabis abuse in adolescence and the risk of psychosis: a brief review of the preclinical evidence. ( 23916409 )
2014
33
Additive effects of childhood abuse and cannabis abuse on clinical expressions of bipolar disorders. ( 24028906 )
2014
34
Psychometric properties of the Cannabis Abuse Screening Test in Hungarian samples of adolescents and young adults. ( 24217457 )
2014
35
Elevated homocysteine level in first-episode schizophrenia patients--the relevance of family history of schizophrenia and lifetime diagnosis of cannabis abuse. ( 24682777 )
2014
36
Cannabis abuse and age at onset in schizophrenia patients with large, rare copy number variants. ( 24685822 )
2014
37
Increased CB2 mRNA and anandamide in human blood after cessation of cannabis abuse. ( 24788457 )
2014
38
Cannabinoid hyperemesis should be recognised as an effect of chronic cannabis abuse. ( 25120899 )
2014
39
Long-term cannabis abuse and early-onset cannabis use increase the severity of cocaine withdrawal during detoxification and rehospitalization rates due to cocaine dependence. ( 25262527 )
2014
40
Predicting cannabis abuse screening test (CAST) scores: a recursive partitioning analysis using survey data from Czech Republic, Italy, the Netherlands and Sweden. ( 25264894 )
2014
41
Prolonged atrial fibrillation precipitated by new-onset seizures and marijuana abuse. ( 24420812 )
2014
42
Late onset epilepsy associated with marijuana abuse: a case report with MRI findings. ( 25120871 )
2014
43
Acute temporal lobe infarction in a young patient associated with marijuana abuse: An unusual cause of stroke. ( 25215152 )
2014
44
Chronic cannabis abuse, delta-9-tetrahydrocannabinol and thyroid function. ( 22821384 )
2013
45
Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence. ( 22907121 )
2013
46
Monitoring of chronic Cannabis abuse: an LC-MS/MS method for hair analysis. ( 23305934 )
2013
47
Adolescent ischemic stroke associated with anabolic steroid and cannabis abuse. ( 23382306 )
2013
48
Contributions of ethnicity to differential item functioning of cannabis abuse and dependence symptoms. ( 23384380 )
2013
49
A validation of the Cannabis Abuse Screening Test (CAST) using a latent class analysis of the DSM-IV among adolescents. ( 23519957 )
2013
50
WITHDRAWN: Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings. ( 23780682 )
2013

Variations for Cannabis Abuse

Expression for Cannabis Abuse

Search GEO for disease gene expression data for Cannabis Abuse.

Pathways for Cannabis Abuse

GO Terms for Cannabis Abuse

Cellular components related to Cannabis Abuse according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 dendrite GO:0030425 9.26 BDNF CNR2 COMT NGF
2 axon GO:0030424 8.92 BDNF CNR1 COMT NGF

Biological processes related to Cannabis Abuse according to GeneCards Suite gene sharing:

(show all 17)
# Name GO ID Score Top Affiliating Genes
1 response to lipopolysaccharide GO:0032496 9.63 CNR1 CNR2 COMT
2 neuron projection morphogenesis GO:0048812 9.57 BDNF NGF
3 G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger GO:0007187 9.56 CNR1 CNR2
4 modulation of chemical synaptic transmission GO:0050804 9.55 BDNF NGF
5 sensory perception of pain GO:0019233 9.54 CNR1 CNR2
6 response to nicotine GO:0035094 9.52 CHRNB3 CNR1
7 peripheral nervous system development GO:0007422 9.51 BDNF NGF
8 regulation of neuron differentiation GO:0045664 9.49 BDNF NGF
9 neurotrophin TRK receptor signaling pathway GO:0048011 9.48 BDNF NGF
10 nerve development GO:0021675 9.43 BDNF NGF
11 memory GO:0007613 9.43 BDNF CNR1 NGF
12 nerve growth factor signaling pathway GO:0038180 9.4 BDNF NGF
13 negative regulation of nitric-oxide synthase activity GO:0051001 9.37 CNR1 CNR2
14 positive regulation of collateral sprouting GO:0048672 9.32 BDNF NGF
15 negative regulation of mast cell activation GO:0033004 9.16 CNR1 CNR2
16 negative regulation of action potential GO:0045759 8.96 CNR1 CNR2
17 cannabinoid signaling pathway GO:0038171 8.62 CNR1 CNR2

Molecular functions related to Cannabis Abuse according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cannabinoid receptor activity GO:0004949 8.62 CNR1 CNR2

Sources for Cannabis Abuse

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....